Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis

被引:4511
作者
El-Serag, Hashem B. [1 ]
Rudolph, Lenhard
机构
[1] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Ctr Qual Care & Utilizat Studies, Houston, TX USA
[4] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
关键词
D O I
10.1053/j.gastro.2007.04.061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. HCC has several interesting epidemiologic features including dynamic temporal trends; marked variations among geographic regions, racial and ethnic groups, and between men and women; and the presence of several well-documented environmental potentially preventable risk factors. Moreover, there is a growing understanding on the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage. A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC ultimately could improve our current concepts for screening and treatment of this disease.
引用
收藏
页码:2557 / 2576
页数:20
相关论文
共 184 条
  • [51] Rising incidence of hepatocellular carcinoma in the United States
    El-Serag, HB
    Mason, AC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) : 745 - 750
  • [52] Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369
  • [53] Farazi PA, 2003, CANCER RES, V63, P5021
  • [54] FATTOVICH G, 1995, HEPATOLOGY, V21, P77
  • [55] Liver steatosis and chronic hepatitis C: A spurious association?
    Fiore, G
    Fera, G
    Napoli, N
    Vella, F
    Schiraldi, O
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (02) : 125 - 129
  • [56] Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma
    Fracanzani, AL
    Fargion, S
    Stazi, MA
    Valenti, L
    Amoroso, P
    Cariani, E
    Sangiovanni, A
    Tommasini, M
    Rossini, A
    Bertelli, C
    Fatta, E
    Patriarca, V
    Brescianini, S
    Stroffolini, T
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (01) : 27 - 32
  • [57] Estimating progression to cirrhosis in chronic hepatitis C virus infection
    Freeman, AJ
    Dore, GJ
    Law, MG
    Thorpe, M
    Von Overbeck, J
    Lloyd, AR
    Marinos, G
    Kaldor, JM
    [J]. HEPATOLOGY, 2001, 34 (04) : 809 - 816
  • [58] Does coffee protect against hepatocellular carcinoma?
    Gallus, S
    Bertuzzi, M
    Tavani, A
    Bosetti, C
    Negri, E
    La Vecchia, C
    Lagiou, P
    Trichopoulos, D
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (09) : 956 - 959
  • [59] GARNER RC, 1972, CANCER RES, V32, P2058
  • [60] Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study
    Gelatti, U
    Covolo, L
    Franceschini, M
    Pirali, F
    Tagger, A
    Ribero, ML
    Trevisi, P
    Martelli, C
    Nardi, G
    Donato, F
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (04) : 528 - 534